Clinical Trial Update: Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports that warfarin prevents portal vein thrombosis after laparoscopic splenectomy with azygoportal disconnection in patients with ci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Vein Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Yangzhou University | Conditions: Cirrhosis, Hypertension | Phase 4 | Status: COMPLETED